It's silly cheap.
As Dr Maiti said, "We should find out pretty early on." It's all about pushing those deep remissions back. His goal is to increase overall survival rate by 10-15%, " but if the trials follow the clinical data it could be much much higher. "
- Forums
- ASX - By Stock
- Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial
It's silly cheap.As Dr Maiti said, "We should find out pretty...
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $23.12M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.7¢ | $14.49K | 518.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1378548 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 158093 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1378548 | 0.027 |
6 | 812615 | 0.026 |
6 | 910000 | 0.025 |
10 | 1506666 | 0.024 |
9 | 2772007 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 158093 | 2 |
0.029 | 25624 | 1 |
0.030 | 221388 | 3 |
0.031 | 451071 | 4 |
0.032 | 1550000 | 3 |
Last trade - 15.59pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
2.8¢ |
  |
Change
-0.002 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
2.8¢ | 2.8¢ | 2.8¢ | 252061 | ||
Last updated 15.47pm 06/05/2024 ? |
Featured News
CHM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online